The 35 references in paper A. Shutov M., V. Serov A., A. Gerdt M., E. Kurzina V., D. Serova V., А. Шутов М., В. Серов А., А. Гердт М., Е. Курзина В., Д. Серова В. (2008) “ХРОНИЧЕСКАЯ БОЛЕЗНЬ ПОЧЕК ПРЕДРАСПОЛАГАЕТ К ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ // CHRONIC KIDNEY DISEASE PREDISPOSES TO ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC HEART FAILURE” / spz:neicon:nefr:y:2008:i:4:p:49-53

1
Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;
(check this in PDF content)
2
5(18):2370-2375 2. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155(5):469- 473
(check this in PDF content)
3
Furberg CD, Psaty BM, Manolio TA et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74(3):236-241
(check this in PDF content)
4
The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327(10):685-691
(check this in PDF content)
5
The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316(23):1429-1435
(check this in PDF content)
6
Atar I, Kona D, A3ikel S et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006;106(1):47-51
(check this in PDF content)
7
Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005;46(5):897-902
(check this in PDF content)
8
Grandea A. Atrial Fibrillation and Dialysis. A Convergence of Risk Factors. Rev Esp Cardiol 2006; 59(8):766-769
(check this in PDF content)
9
Kocheril AG. Arhythmia issues in patients with renal disease. Semin Nephrol 2001;21(1):57-65.
(check this in PDF content)
10
Schneider C, Malisius R, Krause K et al. Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. Eur Heart J 2008; 29(11): 1397-1409
(check this in PDF content)
11
Tsang TS, Gersh BJ, Appleton CP et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002;40(9):1636-1644
(check this in PDF content)
12
Шутов АМ, Машина ТВ, Мардер НЯ и др. Хроничес­ кая сердечная недостаточность у больных с хронической болезнью почек. Нефрология и диализ 2005;7(2):140-144
(check this in PDF content)
13
Hayashi SY Rohani M, Lindholm B et al. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol Dial Transplant 2006;21(1):125-132
(check this in PDF content)
14
Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54(2):230-234
(check this in PDF content)
15
Amann K, Ritz E. Cardiovascular abnormalities in ageing and in uraemia - only analogy or shared pathomechanisms? Nephrol Dial Transplant 1998;13 (Suppl 7):6-11
(check this in PDF content)
16
Национальные Рекомендации ВНОК и ОССН по ди­ агностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2007;39(1):4-41
(check this in PDF content)
17
National Kidney Foundation KD: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1-S266
(check this in PDF content)
18
Шутов АМ, Тармонова ЛЮ. Нарушение функции по­ чек и анемия у больных пожилого возраста с диастоличес­ кой сердечной недостаточностью. Тер. архив 2007; 79(12): 47-51
(check this in PDF content)
19
Lee YA, Liang CS, Lee MA, Lindpaintner K. Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. Proc Natl Acad Sci U S A 1996; 93(20): 11035-11040
(check this in PDF content)
20
Pokharel S, van Geel PP, Sharma UC et al. Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3. Circulation 2004;110(19):3129- 135
(check this in PDF content)
21
Шутов АМ, Мардер НЯ, Хамидулина ГА, Машина ТВ. Диагностика диастолической сердечной недостаточности у больных с хронической болезнью почек. Нефрология 2005; 9(4):35-40
(check this in PDF content)
22
Волков ММ, Смирнов АВ, Дегтярева ОА и др. Каль­ циноз клапанного аппарата сердца и состояние миокарда у пациентов в додиализном периоде хронической болезни почек. Нефрология 2008;12(1):46-52
(check this in PDF content)
23
Шутов АМ, Курзина ЕВ, Серов ВА, Ивашкина ТН. Митральная регургитация у больных с хронической сер­ дечной недостаточностью ассоциирована со снижением функционального состояния почек. Нефрология 2008; 12(1): 19-23
(check this in PDF content)
24
Горохова СГ Оценка влияния дегенеративных изме­ нений клапанов сердца на структуру и функцию левого же­ лудочка у больных сердечной недостаточностью пожилого возраста. Клин геронтол 2000;11-12:18-25
(check this in PDF content)
25
Bruch C, Reinecke H, Rothenburger M et al. Transmitral flow patterns and the presence of chronic kidney disease provide independent and incremental prognostic information in patients with heart failure and systolic dysfunction. J Am Soc Echocardiogr 2007; 20(8):989-997
(check this in PDF content)
26
Acil T, Wichter T, Stypmann J et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure. Int J Cardiol 2005;103(2):175-181
(check this in PDF content)
27
Bruch C, Klem I, Breithardt G et al. Diagnostic usefulness and prognostic implications of the mitral E/E’ ratio in patients with heart failure and severe secondary mitral regurgitation. Am J Cardiol 2007;100(5):860-865
(check this in PDF content)
28
Bruch C, Rothenburger M, Gotzmann M. Chronic kidney disease in patients with chronic heart failure-im pact on intracardiac conduction, diastolic function and prognosis. Int J Cardiol 2007;118(3):375-380
(check this in PDF content)
29
Hillege HL, Girbes AR, De Cam PJ et al. Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation 2000;102:203-210
(check this in PDF content)
30
Goette A, Staack T, Rocken C et al. Increased expression of extracellular signal-regulated kinase and angiotensin­ converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000;35(6):1669-1677
(check this in PDF content)
31
Brenner BM. AMGEN International Prize: the history and future renoprotection. Kidney Int 2003;64(4):1163-1168
(check this in PDF content)
32
Aviles RJ, Martin DO, Apperson-Hansen C et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108(24):3006-3010
(check this in PDF content)
33
Chung MK, Martin DO, Sprecher D et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104(24):2886-2891
(check this in PDF content)
34
Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;
(check this in PDF content)
35
Suppl 1):S117-S131 35. Смирнов АВ, Каюков ИГ, Добронравов ВА. Концеп­ ция факторов риска в нефрологии: вопросы профилактики и лечения хронической болезни почек. Нефрология 2008;12(1):7-13
(check this in PDF content)